Relationship between male pattern baldness and the risk of aggressive prostate cancer: An analysis of the Prostate, Lung, Colorectal, and Ovarian cancer screening trial

Journal of Clinical Oncology

Volumn 33, Issue 5, 2015, Pages 419-425

  Zhou, Cindy Ke ^a,b   Pfeiffer, Ruth M ^a   Cleary, Sean D ^b   Hoffman, Heather J ^b   Levine, Paul H ^b   Chu, Lisa W ^c   Hsing, Ann W ^c   Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FOLLOW UP; GLEASON SCORE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; SKIN CANCER; TIME; TUMOR BIOPSY; ALOPECIA; BIOPSY; CANCER GRADING; CANCER STAGING; CLINICAL TRIAL; EARLY DIAGNOSIS; INCIDENCE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTOR; UNITED STATES;

AGED; ALOPECIA; BIOPSY; EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84922325114     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4279     Document Type: Article

References (68)

1. American Cancer Society: Cancer Facts & Figures 2013. Atlanta, GA, American Cancer Society
2. Bostwick DG, Burke HB, Djakiew D, et al: Human prostate cancer risk factors. Cancer 101: 2371-2490, 2004
3. Haas GP, Sakr WA: Epidemiology of prostate cancer. CA Cancer J Clin 47:273-287, 1997
4. Hsing AW, Chokkalingam AP: Prostate cancer epidemiology. Front Biosci 11:1388-1413, 2006
5. Eeles RA, Kote-Jarai Z, Giles GG, et al: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40:316-321, 2008
6. Shui IM, Lindstro?m S, Kibel AS, et al: Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol 65:1069-1075, 2014
7. Alsantali A, Shapiro J: Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes 16:246-253, 2009
8. Sa'nchez-Chapado M, Olmedilla G, Cabeza M, et al: Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. Prostate 54:238-247, 2003
9. Soos G, Tsakiris I, Szanto J, et al: The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study. Eur Urol 48:739-744, 2005
10. Cremers RG, Aben KK, Vermeulen SH, et al: Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer. Eur J Cancer 46:3294-3299, 2010
11. Demark-Wahnefried W, Schildkraut JM, Thompson D, et al: Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9:325-328, 2000
12. Giles GG, Severi G, Sinclair R, et al: Androgenetic alopecia and prostate cancer: Findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11:549-553, 2002
13. Greenwald P, Damon A, Kirmss V, et al: Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 53:341-346, 1974
14. Hsieh CC, Thanos A, Mitropoulos D, et al: Risk factors for prostate cancer: A case-control study in Greece. Int J Cancer 80:699-703, 1999
15. Oishi K, Okada K, Yoshida O, et al: Casecontrol study of prostatic cancer in Kyoto, Japan: Demographic and some lifestyle risk factors. Prostate 14:117-122, 1989
16. Wright JL, Page ST, Lin DW, et al: Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol 34:131-135, 2010
17. Wynder EL, Mabuchi K, Whitmore WF Jr: Epidemiology of cancer of the prostate. Cancer 28:344-360, 1971
18. Yassa M, Saliou M, De Rycke Y, et al: Male pattern baldness and the risk of prostate cancer. Ann Oncol 22:1824-1827, 2011
19. Muller DC, Giles GG, Sinclair R, et al: Agedependent associations between androgenetic alopecia and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 22:209-215, 2013
20. Zeigler-Johnson C, Morales KH, Spangler E, et al: Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiol Biomarkers Prev 22:589-596, 2013
21. Hawk E, Breslow RA, Graubard BI: Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 9:523-527, 2000
22. Thomas JA, Antonelli JA, Banez LL, et al: Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic casecontrol series of veterans. Cancer Causes Control 24:1045-1052, 2013
23. Amoretti A, Laydner H, Bergfeld W: Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis. J Am Acad Dermatol 68:937-943, 2013
24. Prorok PC, Andriole GL, Bresalier RS, et al: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:273S-309S, 2000
25. Gohagan JK, Prorok PC, Hayes RB, et al: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials 21:251S-272S, 2000
26. Norwood, OT: Hair Transplant Surgery. Springfield, IL, Charles C. Thomas, 1973.
27. Miller AB, Yurgalevitch S, Weissfeld JL, et al: Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:400S-406S, 2000
28. Raghunathan TE, Lepkowski JM, Van Hoewyk J, et al: A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol 27:85-95, 2001
29. Raghunathan TE, Solenberger P, Van Hoewyk J: IVEware: Imputation and variance estimation software. Survey Methodology Program, Survey Research Center, Institute for Social Research, University of Michigan, 2002
30. D'Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998
31. Cooke EW, Shrieve DC, Tward JD: Clinical versus pathologic staging for prostate adenocarcinoma: How do they correlate? Am J Clin Oncol 35:364-368, 2012
32. Yamada T, Hara K, Umematsu H, et al: Male pattern baldness and its association with coronary heart disease: A meta-analysis. BMJ Open 3, 2013
33. Lotufo PA, Chae CU, Ajani UA, et al: Male pattern baldness and coronary heart disease: The Physicians' Health Study. Arch Intern Med 160:165-171, 2000
34. Hamilton JB: Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53:708-728, 1951
35. Hsing AW, Devesa SS: Trends and patterns of prostate cancer: What do they suggest? Epidemiol Rev 23:3-13, 2001
36. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85, 2000
37. Nyholt DR, Gillespie NA, Heath AC, et al: Genetic basis of male pattern baldness. J Invest Dermatol 121:1561-1564, 2003
38. Kote-Jarai Z, Al Olama AA, Giles GG, et al: Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 43:785-791, 2011
39. Ellis JA, Scurrah KJ, Cobb JE, et al: Baldness and the androgen receptor: The AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 121:451-457, 2007
40. Ellis JA, Stebbing M, Harrap SB: Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116: 452-455, 2001
41. Hillmer AM, Flaquer A, Hanneken S, et al: Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome3q26. Am J Hum Genet 82:737-743, 2008
42. Hillmer AM, Hanneken S, Ritzmann S, et al: Genetic variation in the human androgen receptor gene is the major determinant of common earlyonset androgenetic alopecia. Am J Hum Genet 77:140-148, 2005
43. Marks LS: 5alpha-reductase: History and clinical importance. Rev Urol 6:S11-S21, 2004
44. Schweikert HU, Wilson JD: Regulation of human hair growth by steroid hormones: II. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab 39:1012-1019, 1974
45. Price VH, Menefee E, Sanchez M, et al: Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results. J Am Acad Dermatol 55:71-74, 2006
46. Randall VA, Thornton MJ, Messenger AG: Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of scalp. J Endocrinol 133:141-147, 1992
47. Sawaya ME, Honig LS, Hsia SL: Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness. J Invest Dermatol 92:91-95, 1989
48. Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, et al: Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100:170-183, 2008
49. Weiss JM, Huang WY, Rinaldi S, et al: Endogenous sex hormones and the risk of prostate cancer: A prospective study. Int J Cancer 122:2345-2350, 2008
50. Gershman B, Shui IM, Stampfer M, et al: Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. Eur Urol 65:683-689, 2014
51. Li X, Huang Y, Fu X, et al: Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer. Mutagenesis 26:371-383, 2011
52. Wang F, Zou YF, Feng XL, et al: CYP17 gene polymorphisms and prostate cancer risk: A metaanalysis based on 38 independent studies. Prostate 71:1167-1177, 2011
53. Chang BL, Zheng SL, Hawkins GA, et al: Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res 62:1784-1789, 2002
54. Jia L, Landan G, Pomerantz M, et al: Functional enhancers at the gene-poor 8q24 cancerlinked locus. Plos Genet 5:e1000597, 2009
55. Lu Y, Zhang Z, Yu H, et al: Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. Prostate 71:955-963, 2011
56. Rowlands MA, Gunnell D, Harris R, et al: Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and metaanalysis. Int J Cancer 124:2416-2429, 2009
57. Platz EA, Pollak MN, Willett WC, et al: Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 42:1003-1007, 2000
58. Signorello LB, Wuu J, Hsieh CC, et al: Hormones and hair patterning in men: A role for insulinlike growth factor 1? J Am Acad Dermatol 40: 200-203, 1999
59. Venkateswaran V, Haddad AQ, Fleshner NE, et al: Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 99:1793-1800, 2007
60. Freedland SJ, Mavropoulos J, Wang A, et al: Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68:11-19, 2008
61. Ngo TH, Barnard RJ, Cohen P, et al: Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res 9:2734-2743, 2003
62. Albanes D, Weinstein SJ, Wright ME, et al: Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101:1272-1279, 2009
63. Hsing AW, Gao YT, Chua S Jr, et al: Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95:67-71, 2003
64. Klemp P, Peters K, Hansted B: Subcutaneous blood flow in early male pattern baldness. J Invest Dermatol 92:725-726, 1989
65. Arias-Santiago S, Gutiérrez-Salmero'n MT, Castellote-Caballero L, et al: Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study. J Am Acad Dermatol 63:420-429, 2010
66. Littman AJ, White E: Reliability and validity of self-reported male balding patterns for use in epidemiologic studies. Ann Epidemiol 15:771-772, 2005
67. Taylor R, Matassa J, Leavy JE, et al: Validity of self reported male balding patterns in epidemiological studies. BMC Public Health 4:60, 2004
68. Setty LR: Hair patterns of scalp of white and negro males. Am J Phys Anthropol 33:49-55, 1970